Financhill
Back

TG Therapeutics Stock Predictions

TG Therapeutics Stock Forecast

  • Over the next 52 weeks, TG Therapeutics has on average historically risen by 9.4% based on the past 27 years of stock performance.
  • TG Therapeutics has risen higher in 11 of those 27 years over the subsequent 52-week period, corresponding to a historical accuracy of 40.74%
  • Is TG Therapeutics Stock Undervalued?
    The current TG Therapeutics [TGTX] share price is $24.65. The Score for TGTX is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.
  • TGTX is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.

Will TG Therapeutics Stock Go Up Next Year?

  • Over the next 52 weeks, TG Therapeutics has on average historically risen by 9.4% based on the past 27 years of stock performance.

TG Therapeutics Stock Rating

Buy
62
TG Therapeutics (TGTX) is a Buy

Is TG Therapeutics overpriced?

  • TG Therapeutics has risen higher in 11 of those 27 years over the subsequent 52-week period, corresponding to a historical accuracy of 40.74%

TG Therapeutics Stock Price History

Is TGTX stock going to rise?

  • The current trend is moderately bullish and TGTX is experiencing slight buying pressure.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
tgtherapeutics.com

52-Week Data

52-Week High:
26.41
52-Week Low:
6.46

Prediction Charts

Market Cap:
3.82B
Price in USD:
24.65
Volume:
33.12M
Beta:
0.95

Technical Analysis

SMA50:
22.03
SMA100:
19.63
SMA200:
17.69
52-Wk Change:
165.05%

Stock Predictions

  • Is TG Therapeutics stock public?
    Yes, TG Therapeutics is a publicly traded company.
  • What is the TG Therapeutics stock quote today?
    The TG Therapeutics stock price is 24.65 USD today.
  • How to buy TG Therapeutics stock online?
    You can buy TG Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Sep-3 23.92 22.61 25.70 22.16
Sep-4 22.09 22.08 23.03 21.74
Sep-5 21.97 21.46 22.28 21.26
Sep-6 21.49 22.06 22.17 21.11
Sep-9 23.24 23.74 24.50 22.82
Sep-10 23.75 23.53 24.01 22.52
Sep-11 23.43 23.07 23.91 23.01
Sep-12 22.85 23.19 23.89 22.83
Sep-13 23.31 23.73 24.39 23.26
Sep-16 23.81 24.89 25.87 23.46
Sep-17 25.02 25.08 26.03 24.90
Sep-18 26.25 25.25 26.41 25.06
Sep-19 25.60 25.28 26.09 25.09
Sep-20 25.32 24.65 25.34 23.77

TG Therapeutics Earnings

TG Therapeutics Earnings Report: Per Share TG Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.

TG Therapeutics Forecast Revenue Growth

TG Therapeutics Stock Analysis: Historical quarterly revenues per share for TG Therapeutics and historical quarterly revenue growth:

  • Analysts estimate an earnings increase this quarter of $0.07 per share, an increase next quarter of $0.22 per share, an increase this year of $0.09 per share, and an increase next year of $0.63 per share.

* TG Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.